INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES. (2024). CAHIERS MAGELLANES-NS, 6(2), 3635-3642. http://cahiersmagellanes.com/index.php/CMN/article/view/633